Milo Health — Breakeven Model

Gross profit basis · All assumptions visible · Interactive sensitivities · Hormone optimization telehealth

$500
45%

Gross margin source: Hims & Hers 79–83% (SEC 8-K 2023–24) achieved via owned 503B facility. Milo uses third-party 503A pharmacy — realistic range 40–55%. Base case: 45%.

One-time startup costs

Total startup

Monthly fixed costs

Revenue & patient assumptions

Gross profit waterfall (per patient / month)

How breakeven is calculated

Monthly milestones

Cumulative cash position

Cumulative cash (left axis) Gross profit/mo (right) Opex/mo (right)
Milo Health cumulative cash position chart.

Scenario comparison